Dr. William Benefield Jr., Pharm D., BCPP, FASCP

University of Texas at San Antonio and Austin

Dr. William Benefield graduated with honors from Auburn University with a BS in Pharmacy and received his Doctorate in Pharmacy degree from the University of Texas at Austin and the University of Texas Health Center at San Antonio. Dr. Benefield completed his residency in Psychiatric Pharmacy Practice at the University of Texas Health Science Center at San Antonio. He has been board certified in Psychiatric Pharmacy since 1997 and is a founding member of CPNP. He is currently a Clinical Assistant Professor of Psychiatry at the University of Texas. He has practiced in the areas of developmental disabilities, hospice and long term care for the past 27 years. He has authored and co-authored chapters in Pharmacotherapy, the Pharmacotherapy Case Book, and Applied Therapeutics. He has presented at the national meetings of the ACCP, ASCP, American Epilepsy Society, American Academy of Neurology, and NCDEU.

Friday April 19, 2024

EPILEPSY

ACPE# TBA

Objectives:

1.  Describe the signs & symptoms, diagnostic criteria, and pathophysiology for the various types of seizures.

2.  Discuss the efficacy of pharmacologic and non-pharmacologic treatment options in the acute and long-term management of epilepsy.

3.  Understand the mechanisms of action, pharmacokinetic, pharmacodynamic, adverse events, significant drug interactions, and warning/precautions for medications used in epilepsy.

4.  Recognize an evidence-based drug therapy regimen (drug, dose, schedule, and duration of therapy) for stabilizing symptoms and preventing relapse given the clinical presentation of a specific patient.

5.  Outline a plan for monitoring and managing the safety and efficacy of anticonvulsant drug therapy.

6.  Review the management of epilepsy in special populations (pregnancy/lactation, children, elderly).

Saturday April 20, 2024

NEUROCOGNITIVE DISORDERS (ALZHEIMER’S DISEASE, VASCULAR DEMENTIA, DEMENTIA WITH LEWY BODIES, & DELIRIUM)

ACPE# TBA

Objectives:

1.  Describe the signs & symptoms, diagnostic criteria, and pathophysiology for neurocognitive disorders.

2.  Review the use of common rating scales for research, diagnosis, and management of neurocognitive disorders.

3.  Discuss the efficacy of pharmacologic and non-pharmacologic treatment options in the acute and long-term management of neurocognitive disorders.

4.  Understand the mechanisms of action, pharmacokinetic, pharmacodynamic, adverse events, significant drug interactions, and warning/precautions for medications used in neurocognitive disorders.

5.  Recognize an evidence-based drug therapy regimen (drug, dose, schedule, and duration of therapy) for stabilizing symptoms and preventing relapse given the clinical presentation of a specific patient.

6.  Outline a plan for monitoring and managing the safety and efficacy of drug therapy.

Sunday April 21, 2024

NEUROLOGY UPDATE: PARKINSON’S DISEASE, MULTIPLE SCLEROSIS, HEADACHE/MIGRAINE, TRAUMATIC BRAIN INJURY, NEUROPATHIC PAIN, & FIBROMYALGIA

ACPE# TBA

Objectives:

1.  Describe the signs & symptoms, diagnostic criteria, and pathophysiology for Parkinson’s Disease, multiple sclerosis, headache/migraine, traumatic brain injury, neuropathic pain, and fibromyalgia.

2.  Discuss the efficacy of pharmacologic and non-pharmacologic treatment options in the acute and long-term management of these neurologic disorders.

3.  Understand the mechanisms of action, pharmacokinetic, pharmacodynamic, adverse events, significant drug interactions, and warning/precautions for medications used in these neurologic disorders.

4.  Recognize an evidence-based drug therapy regimen (drug, dose, schedule, and duration of therapy) for stabilizing symptoms and preventing relapse given the clinical presentation of a specific patient.

5.  Outline a plan for monitoring and managing the safety and efficacy of drug therapy.

6.  Review the management of neurologic disorders in special populations (pregnancy/lactation, children, elderly).